Rhodemarie Maron

Rhodemarie Maron practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Rhodemarie Maron's NPI, 1699982488, was assigned on May 17, 2007. Rhodemarie Maron graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2003. Rhodemarie Maron holds Alabama license 892.

Rhodemarie Maron's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Rhodemarie Maron's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Rhodemarie Maron is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Rhodemarie Maron to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rhodemarie Maron practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Rhodemarie Maron's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Rhodemarie Maron is board certified in 2005 - 2025 by the AL State License. Rhodemarie Maron is licensed in Alabama.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain and migraine and chronic headache among the conditions Rhodemarie Maron treats.

CMS data shows 601 Medicare services from Rhodemarie Maron across 6 procedure codes in 2024, for 243 Medicare patients. Medicare paid $35,876 for them.

CMS counts 243 Medicare patients who saw Rhodemarie Maron in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rhodemarie Maron's median patient age at 63, with 61% women.

In 2024, Rhodemarie Maron wrote 2,024 Medicare Part D claims for 364 patients. 81% of them were for generic drugs. CMS names the drug for 1,808 of them, across 50 drugs with 11 or more claims each, at $1,334,017 in total drug cost. In 2023, CMS named 1,618 claims across 44 drugs.

Rhodemarie Maron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rhodemarie Maron as offering telehealth.

Dmand AI links 1 paper to Rhodemarie Maron.

CMS Open Payments shows 2 general payments to Rhodemarie Maron from 2 drug and device companies from 2017 to 2024. Education make up the largest share, 61% of the total. Merck Sharp & Dohme Corporation paid the most, $18.

Dmand AI lists 2 awards for Rhodemarie Maron, most recently CMS Stage 1 EHR in 2011. Rhodemarie Maron serves on Director Blazer Bolt for Brain Cancer 5k; Blazer Bolt.com.

Rhodemarie Maron graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2003. Rhodemarie Maron is a member of AAN, AOA, Society Neuro Oncology and Society of Neuro Oncology.

Rhodemarie Maron is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.